$ARQQ

Wilder Ben Simon sold $6K of ARQQ

Wilder Ben Simon (Chief Operating Officer) sold 233 shares of Arqit Quantum Inc. (ARQQ) at $23.78 on 2026-10-05.

Original reporting
SEC EDGAR · Wilder Ben Simon
Published Oct 7, 2026, 11:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 11:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ARQQ
Neutral
low confidence
Mentioned
$ARQQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARQQNeutralLow
01

Why it matters

The transaction is a routine, low‑value insider sale with limited market impact.

02

Market read

The filing provides a minor data point for investors tracking insider activity, but is unlikely to affect trading decisions.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed yet.

Relevance 3/10Novelty 3/10Timing: post-market today

Background

SEC Form 4 filing discloses an insider transaction by Arqit Quantum's COO.

Company-level read

Ticker impact

$ARQQNeutralLow confidence
Context

COO Wilder Ben Simon sold 233 shares of ARQQ for $5,542 on 2026-10-05.

Expected impact

likely slight downward pressure as the market prices the insider sell.

Evidence & confidence

Sale size is trivial ($5.5k) and represents a minor portion of holdings; investors typically ignore such small disposals.

Market effects

minimal impact on the quantum technology sector.

none

limited

Counterpoint

If the insider is offloading shares, it could signal concerns not reflected in the price.

Key entities

  • Arqit Quantum Inc.

    Quantum communications firm listed on Nasdaq under ticker ARQQ.

  • Wilder Ben Simon

    Chief Operating Officer of Arqit Quantum.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QNTMedAI 9/10

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).